Carolien Zeetsen

71 CHAPTER Prevalence of cognitive i mpairments in patients with SUD 4 Stimulants (S) Opioids (O) p –value Post–hoc ( n = 100) ( n = 26) ( n = 44) ( n = 1) 46.00 (68.84) 270.00 (–) < 0.01 ( n = 100) ( n = 25) < 0.01 48 (48) 5 (20) 52 (52) 20 (80) ( n = 69) ( n = 20) 5.42 (1.34) 4.30 (2.03) < 0.01 A, C < S 2.48 (1.02) 1.80 (1.36) < 0.01 A, C < S 6.99 (1.74) 5.40 (2.80) < 0.01 A, C < S ( n = 83) ( n = 24) 14.00 (11.50) 10.42 (10.04) 0.11 9.78 (8.88) 8.25 (8.43) 0.13 18.07 (11.24) 12.08 (11.18) < 0.01 A, O < C; A < S 42.10 (27.45) 30.75 (26.45) < 0.01 A < C

RkJQdWJsaXNoZXIy ODAyMDc0